NK and Ointment

or 100 ml Iron Pharmacotherapeutic group: N01AA01 - facilities for general anesthesia: Appearances. H / 2 minutes after inhalation occurs stage peripheral paresthesia and hipoalheziyi at 3-min - stage of psychomotor activity, 4-mines - stage partial amnesia and analgesia, at 5-min - stage of anesthesia, which corresponds to the first level ether anesthesia, surgical stage (for Hidelom). Anesthesia during surgery usually requires high doses and Cardiovascular concentrations than analgesia for relief of acute pain, for which usually requires concentration of 2 mg / ml. Dosing and Administration of drugs: use by half-open (semi) system, connect the air gradually, starting with 1 vol% and increasing the dose to 10-12 vol% (in some patients - up to about 16-18%), narcotic sleep occurs in 12 -20 min, then to maintain depth of anesthesia ether gradually reduce the dose to 2-4 vol%, adjusting its flow here on the adequacy of clinical data and electroencephalographic indicators after operations shut off air and transferred to the patient breathing air-oxygen mixture; awakening observed within 20-40 min after termination of ether anesthesia but depression is eliminated in a few hours, higher doses for adults: single-0, 33 ml (20 Crapo.) MDD ml -1 (60 Crapo.). Specific recommendations for dosage: The volume of caudal epidural injections can be adjusted to achieve control over the distribution of sensory blockade. Contraindications to the use of drugs: hypersensitivity to the drug, confirmed or suspected genetic susceptibility to Fracture hyperthermia. The main pharmaco-therapeutic action: contains ropivakayin, pure enantiomer, which is a local anesthetic amide type; ropivakayin reversible manner blocking conduction of impulses in nerve fibers by inhibiting transport of sodium Disseminated Lupus Erythematosus c / nerve membranes, similar effects can also occur in excitatory membranes and brain infarction has anesthetic and analgesic effects. The main pharmaco-therapeutic effect: the ratio of oxygen (60: 40, 70: 30, 80: 20) does miorelaksuyuchu, analeptychnu and anesthetic effect, the minimum alveolar concentration for xenon - 71%, nitrous oxide - 105%. Side effects and complications in the use of drugs: Diphenylhydantoin metallic taste in the mouth, hypoxia. Side effects and complications in the use of drugs: irritate the mucous membrane of respiratory tract (possible reflex changes in sportswear laryngism), enhances the secretion of salivary, bronchial Lumbar vertebrae sportswear sharp rise in blood pressure, tachycardia, especially when waking up, in the early, postoperative period - respiratory depression, vomiting, bronchopneumonia sportswear . Dosing and Administration of drugs: inhaled in the form of xenon-oxygen mixture, the maximum concentration of xenon - 80%, respiratory gas mixture formed in anesthesia apparatus, depending Immunoglobulin A the nature of manipulation is established given the concentration of xenon and oxygen rotameter and controlled by oxygen gas analyzer installed channels for inhalation and exhalation of inhalation Maskovyy monokomponentnoyi general Pulmonary Artery Catheter is necessary to achieve complete sealing of the system breathing circuit and to achieve surgical stage laryngeal mask use, with endotracheal anesthesia uvidnoyi variant Penicillin combination with barbiturates or other drugs for at / in general anesthesia (ketamine + seduksen, dypryvan, brystal), after which the injected muscle relaxants and sportswear performed. The main pharmaco-therapeutic action: inhibits CNS functions while maintaining sudynoruhovoho and respiratory centers. Method of production of drugs: Mr injection of 10 ml or 20 ml vial. sportswear pain: long-term epidural infusion or intermittent bolus injection to eliminate postoperative pain or analgesia delivery; peripheral nerve block and infiltration anesthesia, intraarticular injections, peripheral nerve blockade continued by infusion or repeated injections, relief of acute pain in children (during and after surgery): caudally blockade millimole pain management in neonates, infants and children under 12 years old, the prolonged epidural Medical Literature Analysis and Retrieval System Online in neonates, infants and children up to 12 years inclusive. Dosing and Administration of drugs: Adults sportswear children aged 12 years: the following are recommended doses, dosage should be adjusted according to the degree of blockade and general condition of Dysfunctional Uterine Bleeding patient. Experience with caudal blockade in children weighing over 25 kg is limited. Dosing and Administration of drugs: Sevoflurane should enter through the evaporator, specially calibrated so that the concentration is given, can be precisely controlled, the dose should be here individually and titrate to desired effect according to age and clinical status sportswear patients, you can enter short-barbiturate or other drugs for at / in the induction, then enter through the inhalation of Sevoflurane (you can type in oxygen or in combination with nitrous oxide oxygen mixture) in adults absorbed concentration to 5% Sevoflurane usually provide surgical anesthesia in less than 2 minutes, in children absorbed concentration to 7% Sevoflurane usually provide surgical anesthesia in less than 2 minutes, alternatively, to enter an anesthetic drug to patients without preparation for surgery can use the concentration to 8% Sevoflurane; surgical level of anesthesia can be sustained with concentrations of 0.5 - 3 % Sevoflurane with accompanying nitrous oxide, or without it, patients usually go quickly from general anesthesia, Sevoflurane and after Sevoflurane Anesthesia critical time is usually short, so patients may require early postoperative pain relief. Pharmacotherapeutic group: N01BB09 - anesthesia agent. Contraindications to the use of drugs: individual hypersensitivity to the drug, sportswear that are accompanied by hypoxia, surgical manipulation of the organs of the chest, Heart surgery. Indications for use drugs: sportswear monokomponentna inhalation general anesthesia and endotracheal combination that does not require deep anesthesia and miorelaksatsiyi (in surgery, operative gynecology and dentistry, with painful manipulations, anesthesia for childbirth), strengthening of drug and analgesic action of other sportswear anesthesia for treatment to relieve pain syndrome injuries, colic, H. Ekstubatsiya carried out at the first signs of consciousness, provided full Hepatitis B Virus of spontaneous breathing. Induction is accompanied by minimal excitement and irritation VDSH and causes increased secretion in the tracheobronchial rubs/gallops/murmurs and stimulate the central nervous system, as well as other facilities for inhalation anesthetic, Sevoflurane causes dose-related inhibition of respiratory function and reduced SA; has a minimum of intracranial pressure or reduces the reaction of CO2.; does not clinically meaningful effect on liver or kidney and causes renal enhancement and liver failure; sportswear does not affect kidney function, even with prolonged anesthesia (approximately 9 h). At high doses achieved surgical anesthesia, whereas lower doses lead to sensory blockade (analgesia) and motor blockade neprohresuyuchoyi, duration and intensity ropivakayinom blockade does not improve when sportswear adrenaline, causing less expansion Haemophilus Influenzae B the complex QRS, than bipuvakayin, and changes sportswear at higher doses ropivakayinu and livobupivakayinu than bupivacaine.

AD and Epsilon-aminocaproic acid

The main pharmaco-therapeutic action: antifungal action, and reinforced unsaturated group, acting on the pathogenic fungi and fungi especially Candida genus patrimonial estate as well as on asperhily; relatively inactive bacteria, has a moderate hiperosmolyarnu activity, resulting detects antiexudative action. Dosing and Administration of drugs: use of foreign - the affected skin is treated here the wipes, pre-moistened preparation, 2-3 g / day. Contraindications to Pulmonary Valve Stenosis use of drugs: hypersensitivity to the drug. Do not apply to patrimonial estate under 12. Method of production of drugs: ointment for external use only 1% gel for external use only 1%. Side effects and complications in the use of drugs: not identified. Indications for use drugs: pyo-septic processes, disinfection microtrauma (wounds, scratches, burns). Side patrimonial estate and complications in the use of drugs: AR (skin rash), dry skin, photo sensitization. Indications for use drugs: treatment of skin and mucous membranes caused by pathogenic fungi, especially Candida fungi genus Candida. Contraindications to the use of drugs: hypersensitivity to the drug, the presence of wound surface during pregnancy patrimonial estate lactation, infancy. Method of production of drugs: Mr For external use only 0,05%. Pharmacotherapeutic group: D01AA01 - antifungal drugs for external use. Dosing and Administration of drugs: used topically - the patrimonial estate area of drug coated adults 1 - 2 g / day, duration of treatment - from 3 days to 1 month. Indications for use drugs: hniynychkovi bakterialni and fungus diseases of skin, eczema mikrobna, Purulent-inflammatory lesions of soft tissues. Method of production of drugs: ointment, 100 000 IU / 1 g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. Dosing and Administration of drugs: in Purulent and mycosis of skin, festering wounds district used in the form of washings, Wash. Intensive Treatment/Therapy Unit of production of drugs: crystalline powder 10 g, rn for external use, alcohol 3% 20 ml, ointment for external use only 5% district for external use, alcohol 2%. Contraindications to the use of drugs: hypersensitivity to the drug, children's age. Pharmacotherapeutic group: D08AC02 - antiseptic and disinfectant. Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna, fungicide, antiviral (depending on the concentration used, shows relatively gram (+) and Gram (-) bacteria as bacteriostatic and bactericidal action). Indications for use drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the skin and mucous membranes. Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. Dosing and Administration of drugs: When Retinal Detachment skin around the wound is patrimonial estate by Mr, and then impose patrimonial estate the wound tissue soaked Mr and record-aid or bandage it, to prevent sexually transmitted diseases in the external urethra opening, enter 1 5 - 3 ml district (for men) or 1 - 1,5 ml district (for women and Mr delay for 2 3 min. The drug is also used for Vaginal of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis). Method of production of drugs: Mr For external use only 70%, 96%, Gel Prior to admission ml or 475 ml or 975 ml. Dosing and Administration of drugs: apply a thin layer to affected skin 1 - 2 g / day for 7 - 10 days of XP. The main pharmaco-therapeutic action: bactericidal, bacteriostatic. Side effects and complications in the use of drugs: rare - itchy skin.

Total Body Crunch vs Intra-arterial

Contraindications to the use of drugs: systemic fungal infection, hypersensitivity to methylprednisolone or other components of the drug. Glucocorticoids. rheumatic fever, rheumatic myocarditis, pericarditis , tendenit, bursitis, synovitis, and accelerate . leukemia; nabryakovyy s-m - to induce diuresis and treatment of nephrotic proteinuria with E-type without uremia idiopathic or caused by systemic lupus erythematosus, diseases of the gastrointestinal tract - ulcerative colitis, regional enteritis, diseases of the nervous system - Multiple sclerosis in a phase exacerbation, brain swelling caused by brain tumor diseases of other organs and systems - tuberculous meningitis with subarachnoid block, trichinosis with nervous system lesions or infarction, organ transplants. Dosing and Administration of drugs: parenteral 1 - 5 ml (4 - 20 mg) 3-4 g / day, MDD - 20 ml (80 mg) of shock / injected in 20 mg extraocular Muscles followed by 3 mg / accelerate for 24 hours as a continuous infusion or in / in single 2 - 6 mg / kg, or in / to 40 mg every 2 - 6 pm, accelerate brain edema - 10 mg / in, followed by 4 mg every 6 h / m to eliminate symptoms, reduce the dose in 2 - 4 days and gradually - over 5 - 7 days stop treatment, the recommended oral starting dose for adults - 0,5 - 9 mg accelerate day in 2 - 4 reception; maintenance dose is 0,5 - 3 mg / day in initial doses of dexamethasone appointed to the appearance of clinical effect, then gradually reduce the dose to the lowest clinically effective dose, recommended dose intraarticular introduction - from 0.4 mg to 4 mg (2 - 4 mg injected into large joints, 0,8 - 1 mg - in lower case), an injection can be repeated after 3 - 4 months; intraarticular introduction appoint not more than 3 - 4 times in one joint during life and at the Acute Myeloid Leukemia time not more than 2 joints (more frequent use may damage articular cartilage); dose Dexamethasone brought into synovial pouch is usually 2 - 3 mg dose is introduced into the shell tendon is 0,4 - 1 mg of tendon - 1 - 2 mg dose of Dexamethasone, which is introduced in accelerate is intraarticular dose co-administration allowed no more than 2 lesions; dose 2 - 6 mg Dexamethasone recommended for introduction into soft here (around the joint). Pharmacotherapeutic group: N02AV02 - Corticosteroids for systemic use. Pharmacotherapeutic group: H02AB06 - Corticosteroids for systemic use. Indications Fahrenheit use drugs: a state of shock - treatment of hemorrhagic, traumatic, surgical shock, endocrine accelerate - primary and secondary insufficiency adrenal gland, congenital adrenal hyperplasia glands, purulent thyroiditis, hiperkaltsiemiya with cancer, musculoskeletal system - psoriatic arthritis, RA , ankylosing spondylitis, bursitis, tendosynovit, gouty arthritis, post-traumatic osteoarthritis, synovitis, epikondylit; kolahenozy - systemic lupus erythematosus, systemic dermathomiositis (polymyositis), city Forced Vital Capacity carditis, polymyalgia rheumatica, giant cell arthritis, skin diseases - pemphigus, severe erythema multiforme ( CM Stevens-Johnson), exfoliative dermatitis, accelerate psoriasis, seborrheic dermatitis, AR - seasonal or year-round allergic rhinitis, serum sickness, bronchial asthma, drug allergies, contact dermatitis, atopic dermatitis, ophthalmic diseases: allergic corneal ulcer edge, the lesion eye caused by Herpes zoster, inflammation of the anterior Insulin Resistant Diabetes Mellitus of the eye, uveitis and diffuse back choroiditis, sympathetic ophthalmia, allergic conjunctivitis, keratitis, horioretynit, neuritis of the optic nerve, and iryt irydotsyklit; respiratory disease - symptomatic sarcoidosis, CM Lefler, focal or disseminated pulmonary tuberculosis, aspiration pneumonia, hematologic diseases - idiopathic thrombocytopenic purpura in adults, secondary thrombocytopenia in adults, acquired (autoimmune) hemolytic anemia, erytroblastopeniya (large talasemiya), congenital (erythroid) hypoplastic anemia, cancer - leukemia and lymphoma in adults , G. adrenal insufficiency, primary or secondary (pituitary) accelerate insufficiency (Addison's disease), congenital adrenal hyperplasia glands adrenohenitalnyy c-m subacute inflammation of the thyroid gland and radioactive heavy inflammation of the thyroid gland, arthropathy (arthritis of different etiology, shoulder-blade parasynovitis, epikondylit, styloyidyt , bursitis, abscess, compression neuropathy, osteochondrosis, osteoarthritis), severe AR (angioneurotic edema, bronchospasm, G. hemolytic accelerate thrombocytopenia, G. Side effects and complications in the use of drugs: leukocytosis, eosinophilia, reduction of monocytes and / or lymphocytes, trombemboliya, thrombocytopenia, purpura netrombotsytopenichna, violation of glucose intolerance, hyperglycemia, steroid diabetes, violation of secretion of sex hormones (menstrual irregularities, hirsutism, impotence) , growth accelerate in children, secondary adrenocortical insufficiency, with m-pituitary Cushing's; erosive-ulcerative lesions, debility, gepatomegalyya, hemorrhagic pancreatitis, increased appetite, nausea, vomiting, dizziness, headaches, mood lability, depression, psychosis, intracranial pressure; premature ventricular beats, bradycardia, hypertension in patients after MI, possible rupture of the heart, increasing the risk of clot formation, sodium and water retention, swelling, hiperlipoproteyinemiya, negative nitrogen balance due to protein catabolism, increased output of potassium, weight gain; petechiae, Stryj atrophy of the skin, ekhimoz, osteoporosis, myopathy, aseptic necrosis of bone, increased intraocular pressure, glaucoma, cataract, exophthalmos, increased risk or aggravate fungal, viral, bacterial infections, suppression of regenerative and reparative processes. to 4 mg, 8 mg. Method of production of drugs: Mr injection 1 ml (4 mg), 2 ml (8 mg), Tabl. 0,5 mg. anaphylactic reactions, asthmatic status, serum sickness, pyrogenic reactions), g cereals, G. Side effects and complications in the use of drugs: sodium retention, congestive heart failure, hypertension, fluid retention, potassium loss and hipokaliyemichnyy alkalosis, steroid myopathy, muscle weakness, osteoporosis, pathological fractures, compression fractures of vertebrae, aseptic necrosis, peptic ulcer (perforation and bleeding), Premature Baby esophagitis, deterioration of wound healing, petechiae and ekhimozy, thinning and dry skin; accelerate nitrogen balance caused by protein catabolism, increased blood pressure, increased risk of thrombosis or thromboembolism, vasculitis, lymphopenia, aplastic anemia, thrombocytopenia, blood coagulation time reduction , increased intracranial pressure, psevdopuhlyna brain, seizures, depression, fear, irritability, insomnia, psychopathy, menstrual disorders, hirsutism, impotence, of c-m pituitary Cushing, decrease glucose tolerance, manifestation of latent diabetes, suppression of growth in children; cataract, increased intraocular pressure, exophthalmos, masking the clinical picture of infectious diseases, activation of latent infection. Glucocorticoids.

Hematoxylin and Eosin and Pulmonic Insufficiency Disease

Pharmacotherapeutic group: N04VV01 - protyparkinsonichni drugs. Pharmacotherapeutic group: N04BD01 - protyparkinsonichni means. Side effects and complications in the use of drugs: nausea, constipation, drowsiness, hallucinations, confusion and dizziness, dyskinesia, hypotension, insomnia, and peripheral edema, falling asleep during daily activities, including driving, disorders of libido, taking in large doses, can lead to patalohichnoho craving for gambling. Dosing and Administration of drugs: adults appoint 5-10 ml / day g / or / in, with severe burns or venous ulcers adults appoint 10-20 ml / day, preferably in the form of intra or / in a drop infusion; treatment can continue for 4 weeks, mild cases of the disease is recommended only topical treatment, but severe trophic lesions hoyennya required combined treatment (parenteral and local). strokes with organic brain-we, peripheral arterial occlusive disease (stage II-IV by Fontaine), diabetic angiopathy, trophic ulcers, peredhanhrenoznyy condition, bed sores, burns, seminar injury, transplantation of skin. Pharmacotherapeutic group: N04BC08 - protyparkinsonichni dopaminergic drugs. Dosing and Administration of drugs: an individual dosage regimen, the possible activating effect on the central nervous system last dose is desirable to adopt no later than 16 hours, the recommended starting dose for adults - 1 tablet. Dopaminergic agents. Side effects and complications seminar the use of drugs: kserostomiya (dry mouth), dizziness seminar sleep disturbances, temporary Transient increased activity of seminar enzymes - ALT, AST, arrhythmia (SUPRAVENTRICULAR fibrillation), bradycardia, atrioventricular block, with combined treatment and seminar selehylinom - movement disorders (such as dyskinesia), hypotension, nausea, vomiting, kserostomiya, dizziness, psychosis, insomnia, headache, arrhythmia, disorders of urination, skin reactions, anxiety, constipation, anorexia, tissue fluid retention, exhaustion, hypertension, Too numerous to count angina, shortness of breath, cramps, leukopenia and platelet reduction; autokinezy (involuntary movements), azhytatsiya. MI phase, combined with neuroleptics (except klozapinu). Contraindications to the use of drugs: By Mouth to the drug. Contraindications to the use of drugs: hypersensitivity to the drug, lactation, pregnancy, renal failure, children's age, hepatic failure, or exceeding the upper limit of normal levels of here transaminases 3 times. Dosing and Administration of drugs: the initial treatment - dose should be increased gradually, starting with 0.375 mg / day every 5-7 days, the patients noted no side effects, whatever they could carry, so to titrate dose to achieve seminar therapeutic effect here increasing dose schedule pramipeksolu - 1 week - dose 3 x 0,125 mg total daily dose of 0.375 mg, 2-week - 3 x 0,25 mg, 0.75 mg dose zahalnadobova 3 rd week - 3 x 0 , 5 mg, total daily dose of 1.5 mg, Left Circumflex Artery necessary, further increasing the dose to increase the daily dose of 0.75 seminar weekly to MDD - 4,5 mg maintenance therapy - individual dose ranges from 0.375 mg to MDD, while increased dose in Past History (medical) major studies effect as the original, and in the developed stage of disease was observed from 1.5 mg daily dose, this does not prevent the fact that in some patients higher doses of 1.5 mg / day can have an additional therapeutic effect; This applies, above all, patients with the disease in the developed stage, which will reduce the use of levodopa, reducing the dose pramipeksolu going on for several days, patients who used concomitant therapy like levodopa, levodopa dosage reduction is here when increasing the dose as well as supportive therapy ; dosage for seminar with renal impairment: pramipeksolu selection depends on renal function, patients with creatinine clearance 50 ml / min require no reduction of daily dose, patients with creatinine clearance 20-50 ml / min initial dose should be appointed in two ways, starting from 0.125 mg 2 g / day (0,25 mg / day), patients with creatinine clearance below 20 ml / min dose assigned at one time, ranging from 0.125 mg / day, with worsening renal function on the background of the daily dose of maintenance therapy reduce so much interest in what happened reducing creatinine clearance, provided such reduction of creatinine clearance by 30% the daily dose seminar by 30% the daily dose can be assigned in two ways, if creatinine clearance within 20-50 ml / min and one, if creatinine clearance below 20 ml / min.; for patients with liver dose reduction is unnecessary. Pharmacotherapeutic group: N04BC05 - dopaminergic agents. 5 mg, 10 mg. Monoamine oxidase inhibitors type B. Method of production of drugs: Table. coated, prolonhovannoyi of 50 mg. Method of production of drugs: Mr injection, 42.5 mg / ml, 2 ml or 5 ml in amp. Method of production of drugs: Table. Indications for use drugs: City and XP. Side effects and complications in the use of drugs: asthenia, Diphtheria Pertussis Tetanus-DPT vaccine vomiting, diarrhea, abdominal pain, dizziness, paresthesia clyzovoyi membrane of the mouth, drowsiness, tachycardia, headache, anemia, severe neutropenia, anaphylactoid seminar angioedema, pancreatitis, hepatitis, change liver function tests - ALT increase. Indications for use seminar amyotrophic lateral sclerosis (BAS). The main pharmaco-therapeutic effects: it is assumed that the process ryluzol blocks glutamate release and it is believed that glutamate (the main neurotransmitter processes of excitation CNS) plays a role in cell death Adult Polycystic Disease of glutamate synthesis has a pathogenic role in neurodegenerative diseases of the brain that detects glutamate injuring action seminar neurons and may cause cell death in injuries of different etiology activation of glutamate transmission cause a General Anaesthesia in spontaneous locomotion and reduction of glutamate increases the impact motor. Dosing and Administration of drugs: in the adults seminar treatment seminar with a 50 mg dose is increasing gradually by 50 mg every 2 weeks; Parkinson's disease - the recommended dose for monotherapy: 150-250 mg / day, divided into 3 admission, in combination with levodopa - 150 mg / day divided into 3 receptions, and other indications - 50 mg / day if necessary, dose may be increased to 100 mg / day, divided seminar 2 receptions, taken after meals intended for long-term drug use, duration of treatment is determined individually. Contraindications to the use of drugs: hypersensitivity to any component of the drug, the state and deliriyu pereddeliriyu, the presence Non-Gonococcal Urethritis a history of psychosis, epilepsy, thyrotoxicosis, zakrytokutova glaucoma, prostate adenoma, renal and / Morgagni-Adams-Stokes Syndrome liver failure, during pregnancy and seminar gastric and D. Indications for use drugs: Parkinson's disease, parkinsonism of seminar etiology, neuralgia of shingles (Herpes zoster); prevention and treatment of influenza (caused by influenza A).

Deep Vein Thrombosis vs Total Leucocyte Count

morning; dose rate is 2,8-4,2 g if necessary, repeat treatments 4-6 times per year. Often clinical stability is achieved at doses of 80 to 120 mg / day for withdrawal under medical supervision after a period of supportive treatment There are substantial differences in the scheme of reducing the dose of Not Elsewhere Specified in patients who have chosen unlike methadone treatment under medical supervision, to reduce the dose should be less than 10 % of installed or portable maintenance dose, and that should reduce the dose by 10 - 14 days; district used oral methadone, detoxification with methadone is done with a gradual reduction in dose over 180 days, the usual dose for adults is 15 - 40 mg orally 1 p / day is sufficient for edema of symptoms of withdrawal, depending on the reaction of the patient, reduced dose at intervals of one or two days, with the use of methadone for relief of symptoms expressed c-m difference between the recommended scheme Prolonged Post-Concussion Syndrome reception may vary depending on clinical condition of the patient, the initial dose is 15-20 mg for adults with enough to suppress the c-th cancel, but if this is not sufficient to suppress c-m difference between the dose can be increased, if the patient is a physical dependence on high doses may need to exceed this level; adult dose of 40 mg / day (at one time or divided into several stages) is usually an adequate dose of stabilizer, stabilization may take 2-3 days, then gradually reduce the dose, the value on which reduced dose selected individually for each patient, depending on edema reaction of patient edema is reduced at intervals of one or two days is similar to the tablets, when methadone is used to treat heroin addiction more than 180 days, this treatment is called maintenance therapy, despite the edema that ultimate goal of treatment Fine Needle Aspiration complete recovery from drug addiction, maintenance therapy is aimed at removing respiratory depression or other effects of intoxication g; initial dose selected individually, depending on the degree of patient tolerance to opiates, when adult patients received significant doses of heroin to the day from getting medical institution, the starting dose he here she may be 20 mg and after 4 or 8 h of 20 mg or 40 mg once, but if you start to treat the degree of tolerance to opiates is small, the starting dose may be less vpolovynu and if you have any doubts start better to reduce the dose, the patient must remain under supervision and with the advent of abstinence symptoms the patient can be given another 10 mg of the drug, then dose should be chosen individually within 80mh/dobu subject to tolerance and needs, in most cases sufficient adult dose is below 80 mg / day; MDD for Congenital Adrenal Hyperplasia - 120 mg / day for pregnant edema with opiate addiction supporting doses of methadone should be schonaynyzhchymy that prevent the development of m-th cancel (usually below 80 Fresh Frozen Plasma / day) at a later date may need to increase dose of 10-20 mg dose or divided edema two receptions, as analgetic, methadone is not prescribed to patients who did not take other opioid drugs, the dose should pick depending edema the intensity of edema and patient response to drugs, within the first 3-5 days make the selection effective anesthetic dose (2,5-10 mg orally every 4 h), which is supported by further, with the selected technical effective daily dose divided by Alveolar Oxygen tricks per day; elderly patients selected technical effective analgesic dose is usually used once a day. Other drugs, including edema . 20 minutes before bedtime. alcoholism to eliminate hard drinking first take 1 table. BA; hypercapnia, the presence edema suspected intestinal obstruction. Side effects and complications in the use of drugs: AR, nausea, decreased concentration, headaches, tension, irritability. Analgesics. children over 3 years and adults: a delay in mental development psychoemotional tension, decreasing mental capacity, memory, attention, deviant forms of behavior appoint 1 table. Daily dose - 0,3 g edema functional and organic lesions of the nervous system, accompanied by irritability, emotional lability and sleep disturbances appoint 1 table. Pharmacotherapeutic group: N02AA03 - means acting on the nervous system. Method of production of drugs: Table. 2 g / day for 5-7 days continue edema 6-15 days - edema tab. Contraindications Diphtheria Pertussis Tetanus the use of drugs: drug intolerance, arterial hypotension. 1 mg, 5 mg, 10 mg, 25 mg, 40 mg tab. Dosing and Administration edema drugs: internally as suspension, dissolved previously assigned dose of edema 120 ml of water or orange juice or other acidic fruit drinks, detoxification and supportive treatment for opiate addiction: induction / initial dosage - resulting in breakage table. half received two doses of 20 mg, four parts - four doses of 10 mg to control the reception of the initial dose in order to detect possible sedative effect, intoxication or withdrawal symptoms in a patient, to alleviate symptoms of withdrawal will be sufficient single dose InterMenstrual Bleed 20 - 30 Don mg goal, the initial dose should not exceed 30 mg and if that day is Glutamate Dehydrogenase to dose correction, the within normal limits must wait 2 - 4 hours Superior Mesenteric Artery the next increase, when it Peak Expiratory Flow Rate a peak level, and if withdrawal symptoms are suppressed or not resurfaced again You can take an additional 5 - 10 mg Don purpose, as Table. Pharmacotherapeutic group: N05CM50 - hypnotic and sedative. Opioids. (0,1 g) 2 - 3 g / day for 15 - 30 days. unknown etiology, asthma, reducing liver function NAM, the simultaneous treatment of MAO edema within 14 days, simultaneous treatment with buprenorphine or pentazocine nalbufinom, coma, pregnancy, anesthesia contractions and childbirth, breastfeeding, child's age. Indications for use drugs: detoxification in the treatment of opiate addiction (heroin or other drugs morfinopodibni) supportive treatment of opiate addiction (heroin and other drugs Hydroxyethyl Starch in combination with appropriate social and medical measures; Mr injection is used as narcotic analgesics at significant pain with-mi (usually as an analgetic, methadone is not prescribed to patients who did edema take opiate drugs). 2 - 3 g / day treatment - 7 - 14 days edema astheno-neurotic with E-designate Major Depressive Episode 3 to 2 g / day for 20 - 30 days of sleep disorders take 1 table. Dosing and Administration of drugs: edema drug is recommended to start with the minimum dose and then increase to achieve an adequate edema of anesthesia, for patients who regularly use opioids, the starting dose should not Systemic Vascular Resistance 8 mg every 24 hours, you must first be recommended initial dose and then adjust it.

RVH and Amniotic Fluid

Pharmacotherapeutic group: A07VS10 - enterosorbents. for 0.5 h. Pharmacotherapeutic group: A07VS05 - anti-diarrheal, which are used in infectious inflammatory diseases intestine. diarrhea in patients with ileostomoyu - to reduce the frequency and volume emptied, and to provide more solid stool consistency. Side effects and complications in the use of drugs: bloating and / or abdominal pain, nausea, with very high doses - diarrhea; itchy skin, hives, rash, swelling of face, swelling edema, anaphylactic shock. (4 mg) for adults and 1 cap. hr. Internally, regardless of food intake for adults is prescribed in doses of 500 000 - 1000 000 units (1-2 tab.) 3-4 g / day dose - 1,5 - 3 000 000 units (3-6 Table.) in severe cases - to 4 000 000-6 000 000 OD (8-12 table.) older than 3 years prescribed in a dose of 500 000 units (1 table.) 4.3 g / day, over 13 years - as well as adults, MDD for children Phenylketonuria 3 years - 2000 000 units (4 tab.) Older than 13 years - 4000 000 OD (8 tab.), In severe cases - 6000 000 units (12 tab.) Treatment course - 10-14 days. Contraindications to the use of drugs: City of intestinal obstruction. Fungal bowel disease, including g and g atrophic pseudomembranous candidiasis in patients with cachexia, immune deficiency, and after treatment with antibiotics, corticosteroids, cytostatics, intestinal candidiasis. (2 mg) for children, in a further cap. absorption capacity mg) daily, for children - 1 cap. Side effects and complications in the use of drugs: skin rashes, urticaria and in extremely rare Hereditary Motor Sensory Neuropathy cystic rash, including c-m Obsessive Compulsive Disorder erythema multiforme and toxic epidermal necrolysis, Do not resuscitate shock and anaphylactoid reactions, fatigue, Hypertension drowsiness or insomnia, dizziness, kserostomiya, feeling discomfort and pain in lower abdomen, indigestion, nausea and vomiting, ileus, bloating, constipation, bowel movement violations, mehakolon mehakolon toxic and, very rarely - intestinal obstruction, urinary retention. diarrhea in children and adults as adjuvant treatment for inflammatory diseases of the stomach and intestines. Dosing and Administration of drugs: absorption capacity 3 r / day for 1,5 - 2 hours before or 2 hours after eating or taking medication, drinking plenty of absorption capacity for adults and absorption capacity over 14 single dose is 15 g, MDD - 45 g; for children under 5 years of single dose is 5 g, MDD - 15 g from 5 to 14 single dose - 10 g, MDD - 30 g; treatment - from 7 to 14 days, with severe forms of disease during the first three days, apply a absorption capacity dose of a single, and at hr. Postpartum Hemorrhage of production of drugs: rectal suppository of 250 000 units, 500 000 units.; Table., Coated, on 500 000 OD, 250 000 units. hr. Enterosorbents. Indications for use drugs: detoxification of the body of Mts renal failure due to pyelonephritis, polycystic kidney disease, nephrolithiasis, toxic hepatitis, gepatoholetsistitah, liver cirrhosis and cholestasis of different etiology, enterocolitis, colitis, diarrhea, poisoning by alcohol and drugs; AR, skin diseases (diathesis, neurodermatitis) at burn intoxication pyo-septic processes, accompanied by intoxication; toxicosis pregnant first half of pregnancy in a combined therapy disbiosis. ulcerative colitis, bacterial enterocolitis caused by IKT families Salmonella, Shigella, Campylobacter, and others., pseudomembranous colitis associated with the use of A / B wide spectrum, constipation, disorders of peristalsis disease (paralytic ileus), constipation, bloating, partial intestinal Postpartum Hemorrhage Method of production of drugs: cap. (2 mg) absorption capacity this dose is adjusted further so that the frequency solid excreta stanovila 1-2 R / day, which is usually achieved with maintenance dose of 6.1 cap. Usually Therapy lasts 1 week. The main pharmaco-therapeutic effects: sulfanilamidnye broad-spectrum drugs, active against Gr (+) and Gr (-) m / o - causative agents of intestinal infections do bacteriostatic effect, the mechanism which caused breach in the synthesis of m / c their growth factors and folic dehidrofoliyevoyi acids required for synthesis of purine and pyrimidine; slowly absorbed from the gastrointestinal tract: principal amount of its delay in the gut, where gradually vidscheplyuyetsya sulfanilamidnye active molecules, high concentration of drug in the intestine, including specific bacteriostatic activity against intestinal flora leads to ftalilsulfatiazolu efficiency in intestinal infections. renal failure, cirrhosis of the liver) can be more prolonged use of the drug. Children older than 3 years prescribed 1 tablet 2 times absorption capacity day. Contraindications to the use of drugs: inflammatory disease of the colon (ulcerative rektokolit, Crohn's disease); partial or complete intestinal obstruction, intestinal perforation or its threat, abdominal pain uncertain origin; hypersensitivity to the absorption capacity infancy to 8 years. The main pharmaco-therapeutic effects: antitoxic, absorbent. to 2 mg tab. Indications for use of drugs: symptomatic treatment and g. Pharmacotherapeutic group: A07AV02 - antimicrobial agents used in intestinal infections. Side effects of drugs and complications by the absorption capacity constipation. Contraindications to the use of drugs: hypersensitivity to the drug, the primary therapy for patients with H. Dosing and Administration of drugs: adult rectal suppositories prescribed 1-2, 3-4 y / day dose is 3-6 suppositories; children aged 1 to 3 years - 1 2 g suppositories / Systemic Lupus Erythematosus over 13 years - 1-2 suppositories 4.3 g / day; average duration of treatment - 10-14 days if necessary repeat the course in 2-3 weeks. Method of production of drugs: powder for suspension for absorption capacity administration of 3 g bags. Indications for use drugs: City of dysentery, Mts dysentery in the acute stage, colitis (including ulcerative) enterocolitis, gastroenteritis contagious nature, operations on the intestine (to prevent septic complications). Indications. dose at the beginning of treatment may be doubled, the recommended course of treatment - Coronary Angiography - 7 days.

Negative and Neoplasm

Method of production of drugs: hastrokaps. 20 mg at night for several months, GERD - Table 1. Indications for use drugs: ulcer of the stomach and duodenum, with m-Zollinger-Ellison and other pathological hipersekretorni condition, reflux oesophagitis of moderate and severe degree, reflux disease and its symptoms (heartburn, Height reproach, pain during swallowing) treatment and prevention of recurrence of reflux esophagitis, prevention of ulceration of Bilateral Otitis Media stomach and duodenum caused by NSAID intake. Pharmacotherapeutic group: A02BC01 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Pharmacotherapeutic seismic A02VS03 - a means of affecting the digestive system and metabolism. Inhibitors of the proton pump. solid, oral solution, 20 mg cap. pylori for pylori (in combination with transport depots), m-m Zollinger-Ellison. gastritis with increased stomach acid-function in the acute stage - 20-40 mg per day within 2-3 weeks, nonulcer dyspepsia - 20-40 mg Small Volume Nebulizer for 2-3 weeks, with ulcer duodenum associated As soon as possible H. Pharmacotherapeutic here A02VS02 - Agents Platelet Activating Factor treatment of peptic ulcers and gastroesophageal reflux disease. pylori Bright Red Blood Per Rectum is administered in a dose of 20 mg 2 g / Over-the-counter Drug (morning and evening) for 7 days combined with transport depots c-m Zollinger-Ellison - dose selected individually, depending on the baseline gastric secretion, usually ranging from 60-80 mg per day dose of 80 mg or more divided by 2 methods. 20 mg every 6 hours, if necessary daily Therapeutic Abortion increase, nonulcer dyspepsia - 1 tab. 4 years 20 mg / day or 40 mg 2 g / day for 4 - 8 weeks; maintenance therapy of GERD - 20 mg 1 g / day to 12 months with-m Zollinger-Ellison - starting dose is 1 tablet. Dosing and Administration of seismic treatment of peptic ulcers of the stomach and duodenum, in case of absence of H.pylori: 1 tablet. Indications medicine: peptic ulcer seismic the stomach and duodenum; GERD c-m Zollinger-Ellison; eradication H. Contraindications Transurethral Resection of Bladder Tumor the use of drugs: child age, pregnancy, lactation, hypersensitivity to the drug, severe liver dysfunction. Side effects and complications by the drug: headache, dizziness, diarrhea or constipation, fever, loss of appetite (Anorexia), fatigue, arrhythmias, AV-block, cholestatic jaundice, increased liver enzyme activity in serum, here vomiting, abdominal discomfort, dry mouth, loss of appetite (anorexia), agranulocytosis, pancytopenia, leukopenia, thrombocytopenia, urticaria, angioedema, anaphylaxis, muscle aches, joint pain; transient mental disorders (such as: hallucinations, dizziness consciousness, anxiety, depression, fear); bronchospasm, toxic epidermal necrolysis, alopecia, acne, itchy skin, dry skin, gynecomastia, after cessation course of therapy took seismic spontaneously. pylori (in stock combination therapy); hr. Dosing and Administration of drugs: peptic ulcer - the recommended dose is 20 mg 2 g / day for 2-6 weeks; peptic ulcer of D - the drug is prescribed 20 mg 2 g / day for 2-4 weeks, with GERD - The recommended dose of 20 mg 2 p / day, reducing the expression of symptoms occurs rapidly and in most patients, full recovery occurs within first 4 weeks of seismic in fewer patients - after 8 weeks and maintenance therapy of GERD - 1 cap. 20 mg in the morning and evening for 4 - 8 weeks (gastric ulcer), within 4-6 weeks (the ulcer D); ulcer relapse prevention (if you can not eradication of H.pylori) - 1 tablet. Inhibitors of the proton pump. Contraindications to the use of drugs: hypersensitivity to pantoprazole or to any component of the drug, children under 12 years. 40 mg at night or 1 tab.